Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 10 - 25    tags : Collaboration    save search

Loulou Foundation Announces Launch of Pre-Competitive Industry Collaboration for CDKL5 Deficiency Disorder Observational Study
Published: 2021-10-25 (Crawled : 14:15) - biospace.com/
RARE F | $43.38 -1.65% -1.68% 770K twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 3.13% C: 2.06%
BIIB | $190.52 -0.85% -0.84% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 2.07% C: 1.48%

collaboration
Second Clinical Trial Collaboration Initiated to Evaluate Datopotamab Deruxtecan in Combination with KEYTRUDA® (pembrolizumab) in Patients with Metastatic Non-Small Cell Lung Cancer
Published: 2021-10-25 (Crawled : 13:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.11% H: 0.03% C: -0.27%

lung cancer collaboration cancer trial initiated keytruda
Marinus Pharmaceuticals Joins the Loulou Foundation in Collaboration on CANDID, a Comprehensive Observational Study in CDKL5 Deficiency Disorder
Published: 2021-10-25 (Crawled : 13:00) - biospace.com/
MRNS | $1.41 -2.08% -2.13% 4.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 4.6% C: 1.99%

collaboration
Lumen and Cisco expand their partnership to help businesses embrace the future of work with advanced communication and collaboration solutions
Published: 2021-10-25 (Crawled : 12:00) - prnewswire.com
LUMN | $1.32 1.52% 6M twitter stocktwits trandingview |
Communications
| | O: -0.48% H: 0.0% C: -1.77%
CSCO | News | $48.11 0.67% 0.64% 10M twitter stocktwits trandingview |
Technology Services
| | O: -0.88% H: 0.55% C: 0.05%

partnership collaboration communication
Xeris Pharmaceuticals Enters Collaboration Agreement With Merck
Published: 2021-10-25 (Crawled : 12:00) - biospace.com/
XERS | $1.76 -1.12% -0.56% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 13.16% H: 0.0% C: -10.7%

collaboration
TCR² Therapeutics Announces Clinical Trial Collaboration Agreement with Bristol Myers Squibb to Evaluate Gavo-cel in Combination with Opdivo® and Yervoy® in Mesothelin-Expressing Solid Tumors
Published: 2021-10-25 (Crawled : 11:00) - globenewswire.com
BMY | $48.3 0.96% 0.33% 8.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.77% C: 0.16%
TCRR 4 | $1.48 3.38% 3.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.88% H: 1.92% C: 0.88%

solid tumors collaboration trial cel
Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma
Published: 2021-10-25 (Crawled : 10:00) - globenewswire.com
EVAX | $4.22 2.68% 2.38% 35K twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist

biotech collaboration iot keytruda
DUCK CREEK ANNOUNCES NEW COLLABORATIVE AGREEMENT WITH TIREA FOCUSED ON THE SPECIALTY MARKET
Published: 2021-10-25 (Crawled : 07:00) - duckcreek.com
DCT | $18.99 0.0% 0 twitter stocktwits trandingview |
Technology Services
| | O: 0.84% H: 1.24% C: -1.8%

collaboration
Gainers vs Losers
59% 41%

Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $1.45 5.84% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.52 100.0% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.421 97.65% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.5 45.65% 470K twitter stocktwits trandingview |

OST | $0.509 23.81% 45.26% 90K twitter stocktwits trandingview |

GDHG | $0.263 21.76% 40.66% 3.1M twitter stocktwits trandingview |

XPON | News | $3.15 63.21% 37.74% 16M twitter stocktwits trandingview |

TIRX | $0.8 65.02% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.82 42.08% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology


Your saved searches
Save your searches and get alerts when important news are released.